Reversal of experimental pulmonary hypertension by PDGF inhibitionRalph T. Schermuly|Journal of Clinical Investigation|2005Cited by 1.1k
Mechanisms of disease: pulmonary arterial hypertensionRalph T. Schermuly, Friedrich Grimminger, Martin R. Wilkins et al.|Nature Reviews Cardiology|2011Cited by 784
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular HypertrophyBaktybek Kojonazarov, Ralph T. Schermuly|American Journal of Respiratory Cell and Molecular Biology|2017Cited by 119
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in RatsMichaela Lang, Ralph T. Schermuly|PLoS ONE|2012Cited by 113
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertensionAstrid Weiß, Ralph T. Schermuly|Nature Communications|2019Cited by 96